Brief: Biofrontera Enters Into License And Supply Agreement With Galenica AB
Dec 7 (Reuters) - BIOFRONTERA AG B8FGn.DE :
* ENTERS INTO A LICENSE AND SUPPLY AGREEMENT WITH GALENICA
AB FOR
THE MARKETING OF AMELUZ® IN SCANDINAVIA
* SIGNED AN EXCLUSIVE LICENSE AND SUPPLY AGREEMENT WITH
GALENICA
AB FOR MARKETING OF BOTH AMELUZ® AND BF-RHODOLED® IN SWEDEN,
NORWAY, DENMARK, FINLAND AND ICELAND
* GALENICA AB RECEIVES EXCLUSIVE DISTRIBUTION RIGHTS FOR
NORDIC
REGIONS, WHEREBY BIOFRONTERA WILL SUPPLY AMELUZ TO GALENICA AT A
TRANSFER PRICE OF 50% OF EXPECTED NET REVENUES
Source text for Eikon: ID:nPexCSKk4a
Further company coverage: B8FGn.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biofrontera AG
See all newsBrief: Biofrontera Says Co And Units Have Entered Into An Agreement With Biofrontera Inc About How To Settle Payment Obligations By Biofrontera Inc
Brief: Biofrontera AG Says Legal Dispute On Import In USA Will Result In Revised Outlook
Brief: Biofrontera AG Resolves Capital Increase From Authorized Capital
Brief: Biofrontera AG Says Plans Capital Reduction And Considers Subsequent Capital Increase From Authorized Capital
Brief: Biofrontera AG Says FY 2022 Total Revenue Amounted To EUR 25.7 Million